It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

Recombinant antibody production involves the use of recombinant DNA technology to produce an antibody. In this blog post, you will learn all about the process of recombinant antibody production ...

Liraglutide is under clinical development by Novo Nordisk and currently in Phase III for Obesity. According to GlobalData, Phase III drugs for Obesity have a 44% phase transition success rate (PTSR) ...

Liraglutide is under development for the treatment of obesity, ileal pouch-anal anastomosis and Alzheimer's disease. It was also under development for non-alcoholic steatohepatitis, psoriatic ...

The news cycle in 2024 was busy to say the least. Chaotic may be the more appropriate term, with an onslaught of election ...

Science often seems like it's always about careful logic, but really, many discoveries have come about entirely by accident.

A NASA spacecraft has made history by surviving its closest-ever approach to the Sun during the Parker Solar Probe mission, a project over six years in the making. The spacecraft was out of ...

He emphasized that in its current form, HMPV is unlikely to cause severe infections, even amid global concerns of a coronavirus-like outbreak.

ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report) was down 5.6% during mid-day trading on Tuesday . The stock traded as low as $2.51 and last traded at $2.53. Approximately 3,579,558 shares were ...

ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report) shares saw strong trading volume on Monday . 5,229,859 shares traded hands during trading, an increase of 3% from the previous session’s volume of ...

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...